Advertisement
open access | | logout
Medical Conferences

Medical Conferences

  • Conference Reports
  • Conference Proceedings
  • Specialties
    • Cardiology
    • Dermatology
    • Endocrinology
    • Gastroenterology
    • Haematology
    • Nephrology
    • Neurology
    • Oncology
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Urology
  • Multimedia
    • Podcast channel
    • Video channel
  • About
    • 2025 Medicom Conference Planning
    • About Conference Proceedings
    • Webinar
Home > Endocrinology > EASD 2020

EASD 2020


EASD 56th Annual Meeting European Association for the Study of Diabetes 21-25 September 2020
  • Read the full Report (e-book)
  • Table of Contents
  • Colophon

Table of Contents



Featured articles

EASD 2020 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom

EASD Round-Up Articles

Ertugliflozin offers some kidney protection

Presented By
Prof. David Cherney, University of Toronto, Canada

DAPA-CKD trial shows extensive benefits of dapagliflozin

Presented By
Prof. Hiddo Heerspink, University of Groningen, the Netherlands

Empagliflozin significantly reduces CV and renal risk

Presented By
Dr Milton Packer, Baylor University Medical Center, Dallas, USA

Poor prognosis for T2D patients on loop diuretics in addition to SGLT2 inhibitor

Presented By
Prof. Pierpaolo Pellicori, University of Glasgow, United Kingdom

Once daily oral treatment with glucokinase activator TTP399 reduced HbA1c in patients with type 1 diabetes

High risk of vascular dementia in patients with T2D

Presented By
Dr Carlos Celis-Morales, University of Glasgow, Scotland

HbA1c reduction with GLP-1RA leads to lower risk of CV events in cardiovascular outcome trials

Presented By
Dr Mart Roosimaa , University of Tartu, Estonia

Diabetes still goes unnoticed, resulting in delayed diagnosis

Presented By
Dr Katie Young, University of Exeter Medical School, United Kingdom

Shared pathways for COVID-19 and diabetes?

Patients with RA have higher risk of developing diabetes

Presented By
Dr Zixing Tian, University of Manchester, United Kingdom

Once-weekly insulin is a promising treatment option

Presented By
Dr Julio Rosenstock, University of Texas Southwestern, USA

Non-invasive monitoring by measuring glycated albumin in tears

Presented By
Dr Masakazu Aihara, University of Tokyo, Japan

More exercise means less risk of all-cause mortality amongst T2D patients.

Presented By
Dr Yun-Ju Lai , Taichung Veterans General Hospital, Taiwan

Intermittent fasting: consuming fewer calories but in a different way.

Presented By
Prof. Krista Varady, University of Illinois, Chicago, USA

Timing of mealtime insulin can affect quality of life

site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com